AROGYA brings together clinicians, basic scientists and translational medical researchers with technology experts and engineers.

Principal Investigator

Ujjwal Neogi, PhD

Ujjwal is an Associate Professor of Virology and Group Leader in Department of Laboratory Medicine, Karolinska Institute. He received the Swedish Research Council establishment grant 2017 to understand the HIV-1 disease control mechanism using a multi-omics system biology approach. His interest is to understand the host immune defenses against viral infections using multi-omics system biology studies and mechanistic understanding through experimental models.


Portrait photo of Susanne Dam Poulsen

Susanne Dam Poulsen, MD, DMSc
Rigshospitalet and University of Copenhagen, Denmark

Susanne Dam Poulsen is a Professor of Infectious Diseases at the University of Copenhagen, Denmark, and has decade-long experience in treating people living with HIV (PWH) with different co-morbidities. She is the custodian of one of the largest European bio-banked HIV aging cohorts named the Copenhagen Comorbidity in HIV-infection (COCOMO), the study for a longitudinal, non-interventional assessment of non-AIDS comorbidity in HIV infection in Denmark.

Portrait photo of Dasja Pajkrt

Dasja Pajkrt, MD, PhD
Amsterdam University Medical Centers, The Netherlands

Dasja Pajkrt is a Viral Pediatric Infectious Diseases Professor at the Amsterdam University Medical Centers (Amsterdam UMC), The Netherlands. She is the Principal Investigator (PI) of the Department of Pediatric Infectious Diseases and the study “Neurological, cardiovascular, visual, and neurocognitive performance in pediatric HIV-1- infected patients as compared to healthy controls (NOVICE)”.  Dasja leads the research group OrganoVIR Labs, where clinicians, virologists, and tissue engineers work together to develop innovative animal-free models for virus research.

Portrait photo of Adithya Sridhar

Adithya Sridhar, PhD
Amsterdam University Medical Centers, The Netherlands

Adithya Sridhar is a senior scientist at the OrganoVIR Labs at the Amsterdam University Medical Centers (Amsterdam UMC), The Netherlands. He has a degree in Biomedical Engineering from the University of Oxford and did his PhD in the lab-on-chip group of Prof. van den Berg at the University of Twente. He has over ten years of experience developing complex in vitro cell culture models. As a Senior Scientist at the Amsterdam UMC, he has set airway, gut, and brain organoid models for virology.

Portrait photo Yasir Ahmed Syed

Yasir Ahmed Syed, PhD
Cardiff University, United Kingdom

Yasir Ahmed Syed is a Lecturer in Neuroscience at Cardiff University, UK. Syed lab is to define the biological basis of neurodevelopmental and neuropsychiatric disorders. Using the patient-derived pluripotent stem cells and differentiating them into multiple neural linage cells and organoids in vitro, the group employs a combination of cellular, genetic, electrophysiological, behavioral, and material science approaches to understand the mechanisms of disease initiation and progression, and ultimately develop novel and reliable drug targets. Within this project, we aim to identify the contribution of neuroinflammation to the pathogenesis of neurodevelopmental disorders and psychiatric phenotypes in PWH.

Piotr Nowak, MD, PhD

Piotr is an Associate Professor at Karolinska Institute and senior consultant, director of HIV Clinical Research Unit and the Therapeutic unit for Microbiota Transplantation at Karolinska University Hospital. His main research interest is to understand the role of the microbiome in chronic infections like HIV /HCV and Mycobacterium tuberculosis and the mechanisms behind the success of microbiome modulation in the clinic through fecal microbial transplantation.

Ulf Landegren, MD, PhD

Ulf is a Professor of Molecular Medicine and the head of the Molecular Tools Research program at the Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala. He has invented several advanced molecular analysis methods including padlock probes and proximity ligation assays. The methods and assays have been successfully applied by researchers worldwide and commercialized by spin-out companies. Prof Landegren holds 45 patents.

Akos Vegvari, PhD

Akos is Associate Professor at Karolinska Institute, Stockholm. He is head of the facility at Proteomics Biomedicum, Karolinska Institute. He has vast experience in mass-spectrometric based method development. His primary research interest is to develop a method for single-cell proteomics using mass spectrometry for studying various processes of biological and medical importance.

Updated by:

Christina Sundqvist 2024-01-12